Dose-Response Relationships for Endocrine Disruptors: What We Know and What We Don't Know

Author： Lucier G.W.  

Publisher： Academic Press

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.26, Iss.1, 1997-08, pp. : 34-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physical Activity and Alcohol Use Disorders: What We Know and What We Don't Know

By Vingren Jakob L.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 69-71

Informa Healthcare

Access to resources Recommend Favorite

Anesthetic Agents and Neuronal Autophagy. What We Know and What We Don't.

By  

Current Medicinal Chemistry, Vol. 25, Iss. 8, 2018-03 ,pp. : 908-916

Bentham Science Publishers

Access to resources Recommend Favorite

Idarucizumab: What Should We Know?

By  

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite

Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

By Jones Drew R   Miller Grover P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 857-874

Informa Healthcare

Access to resources Recommend Favorite

Adenosine Receptors: What We Know and What We are Learning

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 9, 2010-06 ,pp. : 860-877

Bentham Science Publishers

Access to resources Recommend Favorite